News & Press Releases

JD Supra has recognized ten Mintz attorneys in its 2025 Readers’ Choice Awards. The awards recognize attorneys and firms whose articles on the JD Supra platform were most read by C-suite executives, in-house counsel, media, and other professionals during 2024. 

Mintz is a finalist for the “Life Sciences IP Firm of the Year” category in the inaugural Life Sciences Patent Network (LSPN) Awards USA 2025. The awards are organized by Life Sciences Intellectual Property Review and celebrate excellence across the industry—from trailblazing individuals to firms redefining the boundaries of life sciences IP. Judged by an independent panel of experts, the program highlights innovation, dedication, and the unsung heroes driving progress in the life sciences patent community.

Michael Renaud, Chair of Mintz’s Intellectual Property Division, and Member Terri Shieh-Newton have been named finalists in Managing IP’s Americas Awards 2025. The program is the most comprehensive and widely respected IP law firm awards event in the legal industry and covers several IP practice areas and more than 50 jurisdictions.

Mintz has once again been recognized as one of the most active and high-performing International Trade Commission (ITC) law firms in the Patexia 2025 ITC Intelligence Report. 

Super Lawyers has recognized two Mintz attorneys from the firm’s Los Angeles office. Danny Guggenheim, Co-Chair of the firm’s Real Estate Practice, has been selected for the 2025 Southern California Super Lawyers list, marking his ninth consecutive year on the list. Member David Hanna has been selected to the 2025 Southern California Rising Stars list, marking his fifth consecutive year on the list. 

Mintz continues to earn high rankings by Chambers Global, a guide to the top law firms and attorneys worldwide. Four Mintz attorneys and four of the firm’s practices are ranked in the 2025 Chambers Global edition, including two new practice rankings for International Trade: Intellectual Property (Section 337) and Global Multi-Jurisdictional Life Sciences.